Osteoporosis in inflammatory joint diseases

Author： Roux C.  

Publisher： Springer Publishing Company

ISSN： 0937-941X

Source： Osteoporosis International, Vol.22, Iss.2, 2011-02, pp. : 421-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Work in inflammatory and degenerative joint diseases

By Gobelet C.   Luthi F.   Al-Khodairy A. T.   Chamberlain M. A.  

Disability and Rehabilitation, Vol. 29, Iss. 17, 2007-01 ,pp. : 1331-1339

Informa Healthcare

Access to resources Recommend Favorite

An antibody against RANKL for the treatment of osteoporosis, inflammatory and malignant bone diseases

By Maldonado-Gonzales Eduardo  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 17-18, 2010-09 ,pp. : 458-463

Springer Publishing Company

Access to resources Recommend Favorite

Rosuvastatin‐Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1718-1728

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risks and predictors of osteoporosis in patients with inflammatory bowel diseases in an Asian population: a nationwide population‐based cohort study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 2, 2015-02 ,pp. : 235-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apoptosis in Inflammatory Diseases

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 261-262

Karger

Access to resources Recommend Favorite